<DOC>
	<DOCNO>NCT01816932</DOCNO>
	<brief_summary>This pilot study woman desire etonogestrel implant randomize either home office insertion visit . The purpose research study interest , feasibility , rate insertion implantable birth control ( Implanon®/Nexplanon® ) insert home visit appointment compare standard office visit appointment . The ultimate goal study reduce barrier insertion etonogestrel implant increase consistent correct contraception use introduce previously unexplored method access , home visit .</brief_summary>
	<brief_title>Home Office Visit Insertion Implantable Birth Control</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion Women age 18 Was pregnant within last 10 week Interested use etonogestrel implant contraception Willing investigator come home insertion visit Presenting University Hospitals delivery contraception . Has run water work bathroom home Has safe private location home implant insert Exclusion criterion Current history thrombosis thromboembolic disorder Liver tumor active liver disease Undiagnosed abnormal genital bleed Known suspect breast cancer history breast cancer Allergic reaction component ( ethylene vinylacetate , etonogestrel , barium sulfate ) etonogestrel implant local anesthetic Women currently take hepatic enzyme inducer include exclusive barbiturate , bosentan , carbamazepine , felbamate , griseofulvin , oxcarbazepine , phenylbutazone , phenytoin , rifampin , topiramate , protease inhibitor , St. John 's wort Uncontrolled hypertension Housing locate great 10 mile University Hospitals Center Women 's Health The location home place would safe investigator Participant homeless</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>